脑小血管病MRI标志物的存在与模式与复发性脑出血的关联
该研究纳入443例连续脑出血幸存者,基于基线MRI将病因分为混合型小血管病、小动脉硬化、 probable脑淀粉样血管病和隐源性脑出血,随访中位5.7年发现复发59例,复发率最高为脑淀粉样血管病,隐源性脑出血无复发,独立队列CROMIS-2 ICH证实隐源性无复发。
要点
- 脑淀粉样血管病复发率最高为8.5/100人年,混合型小血管病为1.8/100人年,小动脉硬化为0.6/100人年。
- 隐源性脑出血在510人年随访中无复发(97.5%CI 0-0.7),独立队列CROMIS-2 ICH(n=216)亦无复发。
- 脑淀粉样血管病患者中皮质表面铁沉积与复发风险最强相关(HR 5.7,95%CI 2.4-13.6)。
核心结论
- 基于MRI的病因亚型有助于确定脑出血复发风险,脑淀粉样血管病复发风险最高,小动脉硬化复发风险低,隐源性脑出血复发风险可忽略。
研究设计与样本
- 研究为大型连续脑出血幸存者队列,基线有可用MRI,排除大血管、结构性或其他明确继发原因(除小血管病外)。
- 共纳入443例患者,平均年龄67±13岁,女性41%。
- 采用独立多中心队列CROMIS-2 ICH(n=216)验证核心发现。
主要发现
- 443例中,混合型小血管病占36.7%,小动脉硬化占23.6%,脑淀粉样血管病占23.0%,隐源性脑出血占16.7%。
- 中位随访5.7年(四分位距2.9-10.0,共2682人年),59例(13.3%)出现复发性脑出血。
- 每100人年复发率:脑淀粉样血管病8.5(95%CI 6.1-11.7),混合型小血管病1.8(95%CI 1.1-2.9),小动脉硬化0.6(95%CI 0.3-1.5)。
- 隐源性脑出血在510人年随访中无复发(97.5%CI 0-0.7),CROMIS-2 ICH队列中隐源性脑出血亦无复发。
- 脑淀粉样血管病患者中,皮质表面铁沉积与复发风险最强相关(HR 5.7,95%CI 2.4-13.6)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Assessing the risk of recurrent intracerebral hemorrhage (ICH) is of high clinical importance. MRI-based cerebral small vessel disease (SVD) markers may help establish ICH etiologic subtypes (including cryptogenic ICH) relevant for recurrence risk. METHODS: We investigated the risk of recurrent ICH in a large cohort of consecutive ICH survivors with available MRI at baseline. Patients with macrovascular, structural, or other identified secondary causes (other than SVD) were excluded. Based on MRI findings, ICH etiology was defined as probable cerebral amyloid angiopathy (CAA) according to the Boston 2.0 criteria, arteriolosclerosis (nonlobar ICH and additional markers of arteriolosclerosis, absent lobar hemorrhagic lesions), mixed SVD (mixed deep and lobar hemorrhagic changes), or cryptogenic ICH (no MRI markers of SVD). Recurrent ICH was determined using electronic health records and confirmed by neuroimaging. Data from an independent multicenter cohort (CROMIS-2 ICH) were used to confirm core findings. RESULTS: Of 443 patients with ICH (mean age 67 ± 13 years, 41% female), ICH etiology was mixed SVD in 36.7%, arteriolosclerosis in 23.6%, CAA in 23.0%, and cryptogenic ICH in 16.7%. During a median follow-up period of 5.7 years (interquartile range 2.9-10.0, 2,682 patient-years), recurrent ICH was found in 59 individual patients (13.3%). The highest recurrence rate per 100 person-years was detected in patients with CAA (8.5, 95% CI 6.1-11.7), followed by that in those with mixed SVD (1.8, 95% CI 1.1-2.9) and arteriolosclerosis (0.6, 95% CI 0.3-1.5). No recurrent ICH occurred in patients with cryptogenic ICH during 510 person-years follow-up (97.5% CI 0-0.7); this finding was confirmed in an independent cohort (CROMIS-2 ICH, n = 216), in which also there was no recurrence in patients with cryptogenic ICH. In patients with CAA, cortical superficial siderosis was the imaging feature strongest related to ICH recurrence (hazard ratio 5.7, 95% CI 2.4-13.6). DISCUSSION: MRI-based etiologic subtypes are helpful in determining the recurrence risk of ICH; while the highest recurrence risk was found in CAA, recurrence risk was low for arteriolosclerosis and negligible for cryptogenic ICH.
引用
- Fandler-Höfler S, Obergottsberger L, Ambler G, et al. Association of the Presence and Pattern of MRI Markers of Cerebral Small Vessel Disease With Recurrent Intracerebral Hemorrhage. Neurology. 2023. PMID: 37349111. doi:10.1212/WNL.0000000000207510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。